| SARS-CoV-2 variants, spike mutations and immune escape WT Harvey, AM Carabelli, B Jackson, RK Gupta, EC Thomson, ... Nature Reviews Microbiology 19 (7), 409-424, 2021 | 3420 | 2021 |
| Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England NG Davies, S Abbott, RC Barnard, CI Jarvis, AJ Kucharski, JD Munday, ... Science 372 (6538), eabg3055, 2021 | 2633 | 2021 |
| Nanopore sequencing and assembly of a human genome with ultra-long reads M Jain, S Koren, KH Miga, J Quick, AC Rand, TA Sasani, JR Tyson, ... Nature biotechnology 36 (4), 338-345, 2018 | 1995 | 2018 |
| Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ... Nature 593 (7858), 266-269, 2021 | 1177 | 2021 |
| Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1150 | 2021 |
| SARS-CoV-2 evolution during treatment of chronic infection SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ... Nature 592 (7853), 277-282, 2021 | 1004 | 2021 |
| Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ... The Lancet Infectious Diseases 22 (1), 35-42, 2022 | 876 | 2022 |
| Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ... The Lancet 397 (10282), 1351-1362, 2021 | 765 | 2021 |
| Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ... Nature 593 (7857), 136-141, 2021 | 726 | 2021 |
| Transmission of SARS-CoV-2 Lineage B. 1.1. 7 in England: Insights from linking epidemiological and genetic data E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ... MedRxiv, 2020.12. 30.20249034, 2021 | 617 | 2021 |
| Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity EC Thomson, LE Rosen, JG Shepherd, R Spreafico, A da Silva Filipe, ... Cell 184 (5), 1171-1187. e20, 2021 | 590 | 2021 |
| MinION nanopore sequencing identifies the position and structure of a bacterial antibiotic resistance island PM Ashton, S Nair, T Dallman, S Rubino, W Rabsch, S Mwaigwisya, ... Nature biotechnology 33 (3), 296-300, 2015 | 546 | 2015 |
| Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infection T Charalampous, GL Kay, H Richardson, A Aydin, R Baldan, C Jeanes, ... Nature biotechnology 37 (7), 783-792, 2019 | 541 | 2019 |
| SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway BJ Willett, J Grove, OA MacLean, C Wilkie, G De Lorenzo, W Furnon, ... Nature microbiology 7 (8), 1161-1179, 2022 | 521 | 2022 |
| Co-infections: potentially lethal and unexplored in COVID-19 MJ Cox, N Loman, D Bogaert, J O'Grady The Lancet Microbe 1 (1), e11, 2020 | 465 | 2020 |
| Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7 B Meng, SA Kemp, G Papa, R Datir, IATM Ferreira, S Marelli, WT Harvey, ... Cell reports 35 (13), 2021 | 453 | 2021 |
| Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK L Du Plessis, JT McCrone, AE Zarebski, V Hill, C Ruis, B Gutierrez, ... Science 371 (6530), 708-712, 2021 | 395 | 2021 |
| Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study MS Graham, CH Sudre, A May, M Antonelli, B Murray, T Varsavsky, ... The Lancet Public Health 6 (5), e335-e345, 2021 | 370 | 2021 |
| MinION Analysis and Reference Consortium: Phase 1 data release and analysis CLC Ip, M Loose, JR Tyson, M de Cesare, BL Brown, M Jain, RM Leggett, ... F1000Research 4, 2015 | 356 | 2015 |
| SARS-CoV-2 within-host diversity and transmission KA Lythgoe, M Hall, L Ferretti, M de Cesare, G MacIntyre-Cockett, ... Science 372 (6539), eabg0821, 2021 | 338 | 2021 |
Terry SmithProfessor of Biomedical Engineering Science, University of GalwayVerified email at universityofgalway.ie
